Patients with chronic schizophrenia were treated with either propranolol (640 mg daily) or thioridazine (400 mg daily). In a double-blind study lasting five weeks, propranolol was superior to thioridazine on both psychiatrists' and nurses' ratings. Significant improvements were noted with propranolol in both positive (Type I) and negative (Type II) symptoms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1192/bjp.147.6.623 | DOI Listing |
Publication Analysis
Top Keywords
propranolol
4
propranolol thioridazine
4
thioridazine positive
4
positive negative
4
negative symptoms
4
symptoms schizophrenia
4
schizophrenia patients
4
patients chronic
4
chronic schizophrenia
4
schizophrenia treated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!